nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—Atenolol—Procarbazine—hematologic cancer	0.647	1	CrCrCtD
Alprenolol—CYP2D6—Lomustine—hematologic cancer	0.0519	0.189	CbGbCtD
Alprenolol—CYP2D6—Idarubicin—hematologic cancer	0.0463	0.168	CbGbCtD
Alprenolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0394	0.143	CbGbCtD
Alprenolol—CYP2D6—Bortezomib—hematologic cancer	0.0342	0.124	CbGbCtD
Alprenolol—CYP2D6—Imatinib—hematologic cancer	0.0251	0.0912	CbGbCtD
Alprenolol—CYP2D6—Nilotinib—hematologic cancer	0.0228	0.0829	CbGbCtD
Alprenolol—CYP2D6—Vinorelbine—hematologic cancer	0.0226	0.0822	CbGbCtD
Alprenolol—CYP2D6—Vinblastine—hematologic cancer	0.0139	0.0506	CbGbCtD
Alprenolol—CYP2D6—Dexamethasone—hematologic cancer	0.0103	0.0375	CbGbCtD
Alprenolol—CYP2D6—Doxorubicin—hematologic cancer	0.00856	0.0311	CbGbCtD
Alprenolol—Acebutolol—SLC22A1—hematologic cancer	0.00064	0.506	CrCbGaD
Alprenolol—Atenolol—ABCB1—hematologic cancer	0.000202	0.16	CrCbGaD
Alprenolol—Acebutolol—ABCB1—hematologic cancer	0.000186	0.147	CrCbGaD
Alprenolol—Metoprolol—ABCB1—hematologic cancer	0.000157	0.124	CrCbGaD
Alprenolol—Propranolol—ABCB1—hematologic cancer	7.93e-05	0.0627	CrCbGaD
Alprenolol—ADRB3—Signaling Pathways—MTOR—hematologic cancer	1.22e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CB—hematologic cancer	1.22e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	1.22e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	1.22e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	1.22e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	1.22e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	1.22e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	1.22e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	1.21e-05	0.000159	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO2—hematologic cancer	1.21e-05	0.000158	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CSF2—hematologic cancer	1.21e-05	0.000158	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGF1—hematologic cancer	1.21e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	1.2e-05	0.000157	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	1.2e-05	0.000156	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	1.19e-05	0.000156	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	1.19e-05	0.000156	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	1.19e-05	0.000156	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	1.19e-05	0.000156	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	1.19e-05	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	1.18e-05	0.000154	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.17e-05	0.000154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	1.17e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HRAS—hematologic cancer	1.17e-05	0.000153	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JAK1—hematologic cancer	1.17e-05	0.000152	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	1.17e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CDKN1B—hematologic cancer	1.15e-05	0.00015	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SDC1—hematologic cancer	1.15e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	1.14e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—hematologic cancer	1.14e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	1.13e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—hematologic cancer	1.13e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	1.13e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—hematologic cancer	1.12e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—hematologic cancer	1.12e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	1.11e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	1.1e-05	0.000145	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	1.1e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	1.1e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCND1—hematologic cancer	1.1e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—JUN—hematologic cancer	1.09e-05	0.000143	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	1.09e-05	0.000142	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—hematologic cancer	1.08e-05	0.000141	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TERT—hematologic cancer	1.08e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	1.07e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	1.07e-05	0.00014	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CDKN1A—hematologic cancer	1.06e-05	0.000139	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTEN—hematologic cancer	1.06e-05	0.000138	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	1.05e-05	0.000137	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	1.05e-05	0.000137	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—hematologic cancer	1.03e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	1.03e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—hematologic cancer	1.03e-05	0.000135	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TSC2—hematologic cancer	1.03e-05	0.000134	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	1.02e-05	0.000134	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	1.01e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—hematologic cancer	1.01e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	1e-05	0.000131	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	1e-05	0.000131	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	9.91e-06	0.00013	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	9.88e-06	0.000129	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	9.81e-06	0.000128	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SRC—hematologic cancer	9.81e-06	0.000128	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	9.79e-06	0.000128	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	9.79e-06	0.000128	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	9.78e-06	0.000128	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CD44—hematologic cancer	9.76e-06	0.000128	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NQO1—hematologic cancer	9.76e-06	0.000128	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	9.69e-06	0.000127	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	9.69e-06	0.000127	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ESR1—hematologic cancer	9.59e-06	0.000126	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	9.58e-06	0.000125	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	9.58e-06	0.000125	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—hematologic cancer	9.55e-06	0.000125	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	9.5e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FN1—hematologic cancer	9.48e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—hematologic cancer	9.46e-06	0.000124	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NRAS—hematologic cancer	9.44e-06	0.000123	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BAD—hematologic cancer	9.36e-06	0.000123	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	9.36e-06	0.000123	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	9.31e-06	0.000122	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	9.29e-06	0.000122	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	9.27e-06	0.000121	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	9.27e-06	0.000121	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	9.27e-06	0.000121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	9.27e-06	0.000121	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYCS—hematologic cancer	9.23e-06	0.000121	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	9.18e-06	0.00012	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	9.11e-06	0.000119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CD80—hematologic cancer	9.08e-06	0.000119	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	9.08e-06	0.000119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KIT—hematologic cancer	9.07e-06	0.000119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	9.07e-06	0.000119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	9.07e-06	0.000119	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK3—hematologic cancer	9.04e-06	0.000118	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	9.02e-06	0.000118	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	8.91e-06	0.000117	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	8.91e-06	0.000117	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	8.88e-06	0.000116	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	8.83e-06	0.000116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	8.83e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	8.8e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	8.79e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—hematologic cancer	8.79e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—hematologic cancer	8.77e-06	0.000115	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	8.72e-06	0.000114	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	8.68e-06	0.000114	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	8.64e-06	0.000113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CREB1—hematologic cancer	8.63e-06	0.000113	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	8.61e-06	0.000113	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	8.6e-06	0.000112	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BRAF—hematologic cancer	8.52e-06	0.000112	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—hematologic cancer	8.45e-06	0.000111	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6R—hematologic cancer	8.42e-06	0.00011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	8.41e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	8.39e-06	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	8.33e-06	0.000109	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	8.25e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	8.21e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	8.16e-06	0.000107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	8.15e-06	0.000107	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	8.14e-06	0.000106	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KRAS—hematologic cancer	8.12e-06	0.000106	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	8.08e-06	0.000106	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	8.02e-06	0.000105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	7.98e-06	0.000104	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	7.98e-06	0.000104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	7.97e-06	0.000104	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	7.9e-06	0.000103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	7.87e-06	0.000103	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	7.81e-06	0.000102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	7.8e-06	0.000102	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	7.7e-06	0.000101	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	7.7e-06	0.000101	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	7.65e-06	0.0001	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGF2—hematologic cancer	7.63e-06	9.99e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	7.53e-06	9.85e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	7.5e-06	9.81e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	7.48e-06	9.79e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	7.48e-06	9.79e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	7.48e-06	9.79e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	7.47e-06	9.77e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CA—hematologic cancer	7.46e-06	9.76e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	7.33e-06	9.59e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JAK2—hematologic cancer	7.32e-06	9.57e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	7.3e-06	9.56e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	7.26e-06	9.5e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	7.26e-06	9.5e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—hematologic cancer	7.22e-06	9.44e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	7.17e-06	9.38e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MDM2—hematologic cancer	7.14e-06	9.34e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	7.11e-06	9.3e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	7.11e-06	9.3e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MTOR—hematologic cancer	6.95e-06	9.09e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	6.95e-06	9.09e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	6.94e-06	9.07e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HRAS—hematologic cancer	6.9e-06	9.03e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	6.82e-06	8.92e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	6.78e-06	8.88e-05	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	6.74e-06	8.82e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	6.68e-06	8.74e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	6.67e-06	8.73e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	6.67e-06	8.73e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	6.64e-06	8.69e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	6.63e-06	8.68e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	6.61e-06	8.65e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—hematologic cancer	6.61e-06	8.64e-05	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	6.6e-06	8.63e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	6.54e-06	8.55e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	6.53e-06	8.54e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	6.52e-06	8.53e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	6.5e-06	8.51e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	6.49e-06	8.5e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	6.49e-06	8.49e-05	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	6.45e-06	8.44e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—hematologic cancer	6.39e-06	8.36e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—hematologic cancer	6.38e-06	8.35e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	6.36e-06	8.32e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—hematologic cancer	6.35e-06	8.31e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	6.35e-06	8.31e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	6.29e-06	8.23e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	6.28e-06	8.21e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCND1—hematologic cancer	6.22e-06	8.14e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JUN—hematologic cancer	6.21e-06	8.12e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	6.15e-06	8.05e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	6.14e-06	8.03e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	6.14e-06	8.03e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	6.12e-06	8.01e-05	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—hematologic cancer	6.09e-06	7.97e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	6.02e-06	7.87e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	6.01e-06	7.86e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTEN—hematologic cancer	6e-06	7.86e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	5.99e-06	7.84e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	5.99e-06	7.83e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	5.87e-06	7.69e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	5.86e-06	7.66e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	5.86e-06	7.66e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	5.82e-06	7.62e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—hematologic cancer	5.73e-06	7.49e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	5.69e-06	7.45e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	5.67e-06	7.42e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	5.61e-06	7.35e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	5.6e-06	7.33e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SRC—hematologic cancer	5.57e-06	7.29e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.55e-06	7.27e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	5.55e-06	7.26e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	5.49e-06	7.19e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	5.48e-06	7.17e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	5.42e-06	7.1e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—hematologic cancer	5.37e-06	7.03e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	5.36e-06	7.02e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NRAS—hematologic cancer	5.36e-06	7.01e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	5.25e-06	6.86e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	5.22e-06	6.83e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	5.2e-06	6.81e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.15e-06	6.74e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	5.13e-06	6.71e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	5.1e-06	6.68e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	5.09e-06	6.66e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—hematologic cancer	4.99e-06	6.53e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	4.98e-06	6.51e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.88e-06	6.39e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	4.82e-06	6.31e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—hematologic cancer	4.82e-06	6.31e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	4.71e-06	6.17e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.61e-06	6.03e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KRAS—hematologic cancer	4.61e-06	6.03e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	4.43e-06	5.79e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	4.33e-06	5.67e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	4.28e-06	5.61e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.26e-06	5.57e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	4.24e-06	5.54e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	4.19e-06	5.48e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—hematologic cancer	4.1e-06	5.36e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	4.1e-06	5.36e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	4.01e-06	5.24e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	3.92e-06	5.13e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HRAS—hematologic cancer	3.92e-06	5.13e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	3.84e-06	5.02e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—hematologic cancer	3.75e-06	4.91e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTEN—hematologic cancer	3.68e-06	4.81e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	3.62e-06	4.73e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	3.54e-06	4.63e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—hematologic cancer	3.51e-06	4.59e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—hematologic cancer	3.46e-06	4.53e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.59e-06	3.39e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—hematologic cancer	2.12e-06	2.77e-05	CbGpPWpGaD
